Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AstraZeneca

Breast cancer drug blocked for NHS use as price talks break down for third time

Nice said it was ‘extremely disappointed’ it will be unable to recommend trastuzumab deruxtecan, sold under the brand name Enhertu.

Evening Standard

Pharma shares hit as Trump picks RFK Jr to lead health department

Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK

The Guardian - UK

AstraZeneca’s numbers are good but trouble in China could drag it down

Profits beat forecasts but a 17% fall in share price since executives were detained by Beijing may be hard to shake

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca says it takes China investigation ‘very seriously’

UK’s biggest pharmaceutical company ‘committed to China’ as it raises 2024 profit forecast and announces $3.5bn US investment

The Guardian - UK

AstraZeneca boss says firm takes China probe ‘very seriously’

The group’s shares have tumbled after it emerged that the firm’s China president has been detained as Chinese authorities deepen their investigation.

Evening Standard

FTSE 100 Live 12 November: Vodafone and AstraZeneca results fail to revive shares, Metro Bank fined £16m

Cracks are appearing in the labour market after the unemployment rate today rose to 4.3%.

Evening Standard

Pharma Giant AstraZeneca Says China Chief Detained

Leon Wang, president of AstraZeneca China, "has been detained", a representative of the firm's global media team said in an email to AFP.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca shares tumble after reports China unit is linked to insurance fraud

Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price

The Guardian - UK

AstraZeneca drags on FTSE as Wall Street positive amid US election voting

The FTSE 100 finished 11.85 points, or 0.14%, lower to end the day at 8,172.39.

Evening Standard

OBR moving to ‘trust but verify’ relationship with Treasury after ‘black hole’ row – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

US economic growth slows, as Germany avoids recession and France gets Olympics boost – as it happened

Eurozone GDP grew by 0.4% in the last quarter, faster than expected, as Germany’s economy avoids second contraction in a row

The Guardian - UK

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly

The Guardian - UK

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

The Guardian - UK

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Boris Johnson considered invading Holland to seize Covid vaccines

The then prime minister convened a meeting of senior military officials to discuss the plans.

The Guardian - UK

Boris Johnson: we considered ‘aquatic raid’ on Netherlands to seize Covid vaccine

Former prime minister admits in extract from forthcoming book that he discussed possible aquatic operation at height of pandemic

The Independent UK

Nasal spray flu vaccine approved for home use: Here’s what to know

Vaccine provides an alternative to flu shots administered with needles

Medical Daily

First Self-Administered Flu Vaccine For Home Use Gets FDA Approval

FluMist nasal spray manufactured by AstraZeneca is now approved for home use against influenza infection caused by subtypes A and B from ages 2 through 49.

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

FDA clears at-home nasal flu vaccine

AstraZeneca’s FluMist can now be taken at home

The Conversation

Businesses that try to come clean about their impact on nature can end up concealing more than they reveal

Humans have overfished the ocean, cleared forests, polluted water and created a climate crisis by burning fossil fuels. These actions are affecting biodiversity around the world, from remote islands to our own backyards.

Fortune

Fortune LGBTQ+ Leaders

What will the LGBTQ+ Leaders of the future look like? Here are some of the names we expect to see a lot more of in the coming years.

The Independent UK

Man, 27, dies weeks after receiving Covid vaccine he was wrongly invited to take by NHS

Jack Last died after having the AstraZeneca Covid jab following a ‘litany’ of errors by GP services and the NHS

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Guardian - UK

China detains five AstraZeneca staff over ‘data privacy and import breaches’

Detentions involve Chinese citizens who marketed cancer drugs for firm’s oncology division

The Guardian - UK

Britain could be a sci-tech superpower – if the Treasury stopped holding it back

The UK has the research base, the startups, the venture capitalists, but its presence in the global market is pitiful. The chancellor must step in

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.